Zhonglin Li
-
- Cancer-related molecular mechanisms research 5
-
- Liver Disease Diagnosis and Treatment 11
-
- Genetic Associations and Epidemiology 6
-
- Cardiac Valve Diseases and Treatments 6
-
- RNA modifications and cancer 5
- Single-cell and spatial transcriptomics 2
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 4
- Diet, Metabolism, and Disease 3
- Co-authors
- Yohan BosséPatrick MathieuSébastien ThériaultLing YangBenoît J. ArsenaultMarie‐Chloé BoulangerArnaud ChignonHuikuan Chu
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Zhonglin Li
33 papers receiving 423 citations
Peers
Comparison fields: 5 of 85
- Infectious Diseases 62
- Pharmacology 29
- Cancer Research 45
- Computational Theory and Mathematics 45
- Biological Psychiatry 7
Countries citing papers authored by Zhonglin Li
This map shows the geographic impact of Zhonglin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhonglin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhonglin Li more than expected).
Fields of papers citing papers by Zhonglin Li
This network shows the impact of papers produced by Zhonglin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhonglin Li. The network helps show where Zhonglin Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhonglin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 2 | |
| 5 | 2025 | 1 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 6 | |
| 10 | 2023 | 23 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 1 | |
| 13 | 2023 | 0 | |
| 14 | 2022 | 6 | |
| 15 | 2022 | 9 | |
| 16 | 2021 | 10 | |
| 17 | 2021 | 11 | |
| 18 | 2020 | 12 | |
| 19 | 2020 | 17 | |
| 20 | 2019 | 97 |
About Zhonglin Li
Zhonglin Li is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism and Epidemiology, having authored 39 papers that have together received 428 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (11 papers), Genetic Associations and Epidemiology (6 papers), Cardiac Valve Diseases and Treatments (6 papers), Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Diet, Metabolism, and Disease (3 papers) and Single-cell and spatial transcriptomics (2 papers). The work is most often cited by research in Infectious Diseases (62 citations), Pharmacology (29 citations) and Cancer Research (45 citations). Zhonglin Li has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Yohan Bossé, Patrick Mathieu, Sébastien Thériault, Ling Yang, Benoît J. Arsenault, Marie‐Chloé Boulanger, Arnaud Chignon, Huikuan Chu, Mickaël Rosa and Jianping Lin. Their work appears in journals such as Circulation, Journal of Clinical Investigation and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.